[
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
[og_img]
https://www.investing.com/news/press-releases/protara-therapeutics-announces-positive-interim-results-demonstrating-durable-responses-in-the-ongoing-phase-2-advanced2-trial-of-tara002-in-patients-with-nmibc-93CH-4005848
Investing.com
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
Related articles